Published 11/18/2025
Balvanz P, Harris D, Olvera R, Sabounchi N, Bridden C, Carpenter J, Damato-MacPherson C, David J, Fareed N, Gibson E, Huerta T, Hunt T, Kosakowski S, Larochelle M, Lewis N, Lounsbury D, Plagens C, Smeltzer R, Villani J, Wu E, Chase R. Lessons From the Community-Engaged, Data-Driven Selection of Evidence-Based Practice Strategies in the HEALing Communities Study. J Public Health Manag Pract. 2026 Jan-Feb 01; 32(1):25-33. PMID: 41260589.
Published 8/21/2025
Xu KY, Newman TV, McGill LS, Novelli EM, Hillery CA, Buss JL, Gong L, Huang R, Dong F, Stwalley D, Salas J, Liu SA, Scherrer JF, Brown TR, Park TW, LaRochelle MR, Grucza RA, Jonassaint CR. Ten-year trends in opioid prescribing and vaso-occlusive crises in sickle cell disease: a population-based national cohort study (2011-2022). Lancet Reg Health Am. 2025 Oct; 50:101214. PMID: 40894271.
Published 7/9/2025
Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785. PMID: 40684522.